MGTX MeiraGTx Holdings plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MGTX

Price (delayed)

$6.575

Market cap

$391.21M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.79

Enterprise value

$414.2M

MeiraGTx is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in ...

Highlights
MGTX's EPS is down by 42% year-on-year but it is up by 2.8% since the previous quarter
The company's net income fell by 48% YoY
MGTX's equity is down by 44% YoY and by 23% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://meiragtx.com
Peers: MRVI NBIX

Key stats

What are the main financial stats of MGTX
Market
Shares outstanding
59.5M
Market cap
$391.21M
Enterprise value
$414.2M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.55
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$121.01M
EBITDA
-$111.31M
Free cash flow
-$143.3M
Per share
EPS
-$2.79
Free cash flow per share
-$2.95
Book value per share
$1.85
Revenue per share
$0
TBVPS
$5.9
Balance sheet
Total assets
$288.14M
Total liabilities
$197.92M
Debt
$91.77M
Equity
$90.22M
Working capital
$40.38M
Liquidity
Debt to equity
1.02
Current ratio
1.5
Quick ratio
1.3
Net debt/EBITDA
-0.21
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-44.5%
Return on equity
-109.1%
Return on invested capital
-62.1%
Return on capital employed
-58.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MGTX stock price

How has the MeiraGTx Holdings stock price performed over time
Intraday
4.37%
1 week
-13.03%
1 month
22.21%
1 year
-14.5%
YTD
0.84%
QTD
27.18%

Financial performance

How have MeiraGTx Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$133M
Net income
-$128.93M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 48% YoY
MeiraGTx Holdings's operating income has decreased by 13% YoY

Growth

What is MeiraGTx Holdings's growth rate over time

Valuation

What is MeiraGTx Holdings stock price valuation
P/E
N/A
P/B
3.55
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MGTX's EPS is down by 42% year-on-year but it is up by 2.8% since the previous quarter
MGTX's equity is down by 44% YoY and by 23% from the previous quarter
The stock's price to book (P/B) is 31% more than its last 4 quarters average of 2.7 and 4.4% more than its 5-year quarterly average of 3.4

Efficiency

How efficient is MeiraGTx Holdings business performance
MeiraGTx Holdings's return on equity has shrunk by 132% YoY and by 14% QoQ
MGTX's return on assets has dropped by 58% year-on-year
The ROIC rose by 15% QoQ and by 9% YoY

Dividends

What is MGTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MGTX.

Financial health

How did MeiraGTx Holdings financials performed over time
MeiraGTx Holdings's total assets is 46% higher than its total liabilities
The total liabilities has surged by 57% year-on-year
The quick ratio has contracted by 33% YoY and by 22% from the previous quarter
MGTX's equity is down by 44% YoY and by 23% from the previous quarter
The company's debt to equity rose by 31% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.